Filling the need for trusted information on national health issues…

Trending on kff Medicaid Expansion Marketplaces Enrollment

Cost Of New Hepatitis C Drug Out Of Reach For Developing Countries

IRIN: Life-saving hepatitis C drug approved, but cost is high
“Following approvals in the U.S. and Europe this month of a new drug to treat hepatitis C, activists are pushing for the medication to be made available in poor countries, a development reminiscent of the activism that forced down HIV/AIDS drug prices a decade ago in Brazil, South Africa and Thailand…” (12/23).